'MOVEdiabetes'

A cluster randomized controlled trial to increase physical activity in adults with type 2 diabetes in primary health in Oman

Thamra S. Alghafri, Saud Mohamed Alharthi, Yahya Al-Farsi, Abdul Hakeem Alrawahi, Elaine Bannerman, Angela M. Craigie, Annie S. Anderson

Research output: Contribution to journalArticle

Abstract

Objective: This study examined the impact of a multicomponent intervention to increase physical activity (PA) in adults with type 2 diabetes (T2D) in Oman. Research design and methods: This is a cluster randomized controlled trial in eight primary health centers. Participants were physically inactive, aged ≥18 years, and with no contraindication to PA. Patients attending intervention health centers (n=4) received the 'MOVEdiabetes' intervention, which consisted of personalized, individual face-to-face consultations by dietitians. Pedometers and monthly telephone WhatsApp messages were also used. Patients attending comparison health centers received usual care. The primary outcome was change in PA [Metabolic Equivalent(MET).min/week] after 12 months assessed by the Global Physical Activity Questionnaire. The secondary outcomes were changes in daily step counts, sitting time, weight, body mass index, glycated hemoglobin, blood pressure and lipids. Results: Of the 232 participants (59.1% female, mean (SD) age 44.2 (8.1) years), 75% completed the study. At 12 months, the mean change in MET.min/week was +631.3 (95% CI 369.4 to 893.2) in the intervention group (IG) vs +183.2 (95% CI 83.3 to 283.0) in the comparison group, with a significant between-group difference of +447.4 (95% CI 150.7 to 744.1). The odds of meeting PA recommendations were 1.9 times higher in the IG (95% CI 1.2 to 3.3). Significant between-group differences in favor of IG were detected for mean steps/day (+757, 95% CI 18 to 1531) and sitting time hours/ per day (-1.5, 95% CI -2.4 to -0.7). Clinical measures of systolic and diastolic blood pressure and triglycerides also showed significant intervention effects. Conclusions: 'MOVEdiabetes' was effective in increasing PA, the likelihood of meeting PA recommendations, and providing cardioprotective benefits in adults with T2D attending primary care.

Original languageEnglish
Article numbere000605
JournalBMJ Open Diabetes Research and Care
Volume6
Issue number1
DOIs
Publication statusPublished - Oct 1 2018

Fingerprint

Oman
Type 2 Diabetes Mellitus
Randomized Controlled Trials
Exercise
Health
Metabolic Equivalent
Blood Pressure
Nutritionists
Glycosylated Hemoglobin A
Telephone
Primary Health Care
Triglycerides
Body Mass Index
Research Design
Referral and Consultation
Lipids
Weights and Measures

Keywords

  • intervention
  • physical activity
  • primary health care
  • type 2 diabetes

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

'MOVEdiabetes' : A cluster randomized controlled trial to increase physical activity in adults with type 2 diabetes in primary health in Oman. / Alghafri, Thamra S.; Alharthi, Saud Mohamed; Al-Farsi, Yahya; Alrawahi, Abdul Hakeem; Bannerman, Elaine; Craigie, Angela M.; Anderson, Annie S.

In: BMJ Open Diabetes Research and Care, Vol. 6, No. 1, e000605, 01.10.2018.

Research output: Contribution to journalArticle

Alghafri, Thamra S. ; Alharthi, Saud Mohamed ; Al-Farsi, Yahya ; Alrawahi, Abdul Hakeem ; Bannerman, Elaine ; Craigie, Angela M. ; Anderson, Annie S. / 'MOVEdiabetes' : A cluster randomized controlled trial to increase physical activity in adults with type 2 diabetes in primary health in Oman. In: BMJ Open Diabetes Research and Care. 2018 ; Vol. 6, No. 1.
@article{14f5e103bbf84da0be5935419fc532bd,
title = "'MOVEdiabetes': A cluster randomized controlled trial to increase physical activity in adults with type 2 diabetes in primary health in Oman",
abstract = "Objective: This study examined the impact of a multicomponent intervention to increase physical activity (PA) in adults with type 2 diabetes (T2D) in Oman. Research design and methods: This is a cluster randomized controlled trial in eight primary health centers. Participants were physically inactive, aged ≥18 years, and with no contraindication to PA. Patients attending intervention health centers (n=4) received the 'MOVEdiabetes' intervention, which consisted of personalized, individual face-to-face consultations by dietitians. Pedometers and monthly telephone WhatsApp messages were also used. Patients attending comparison health centers received usual care. The primary outcome was change in PA [Metabolic Equivalent(MET).min/week] after 12 months assessed by the Global Physical Activity Questionnaire. The secondary outcomes were changes in daily step counts, sitting time, weight, body mass index, glycated hemoglobin, blood pressure and lipids. Results: Of the 232 participants (59.1{\%} female, mean (SD) age 44.2 (8.1) years), 75{\%} completed the study. At 12 months, the mean change in MET.min/week was +631.3 (95{\%} CI 369.4 to 893.2) in the intervention group (IG) vs +183.2 (95{\%} CI 83.3 to 283.0) in the comparison group, with a significant between-group difference of +447.4 (95{\%} CI 150.7 to 744.1). The odds of meeting PA recommendations were 1.9 times higher in the IG (95{\%} CI 1.2 to 3.3). Significant between-group differences in favor of IG were detected for mean steps/day (+757, 95{\%} CI 18 to 1531) and sitting time hours/ per day (-1.5, 95{\%} CI -2.4 to -0.7). Clinical measures of systolic and diastolic blood pressure and triglycerides also showed significant intervention effects. Conclusions: 'MOVEdiabetes' was effective in increasing PA, the likelihood of meeting PA recommendations, and providing cardioprotective benefits in adults with T2D attending primary care.",
keywords = "intervention, physical activity, primary health care, type 2 diabetes",
author = "Alghafri, {Thamra S.} and Alharthi, {Saud Mohamed} and Yahya Al-Farsi and Alrawahi, {Abdul Hakeem} and Elaine Bannerman and Craigie, {Angela M.} and Anderson, {Annie S.}",
year = "2018",
month = "10",
day = "1",
doi = "10.1136/bmjdrc-2018-000605",
language = "English",
volume = "6",
journal = "BMJ Open Diabetes Research and Care",
issn = "2052-4897",
publisher = "BMJ Publishing Group",
number = "1",

}

TY - JOUR

T1 - 'MOVEdiabetes'

T2 - A cluster randomized controlled trial to increase physical activity in adults with type 2 diabetes in primary health in Oman

AU - Alghafri, Thamra S.

AU - Alharthi, Saud Mohamed

AU - Al-Farsi, Yahya

AU - Alrawahi, Abdul Hakeem

AU - Bannerman, Elaine

AU - Craigie, Angela M.

AU - Anderson, Annie S.

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Objective: This study examined the impact of a multicomponent intervention to increase physical activity (PA) in adults with type 2 diabetes (T2D) in Oman. Research design and methods: This is a cluster randomized controlled trial in eight primary health centers. Participants were physically inactive, aged ≥18 years, and with no contraindication to PA. Patients attending intervention health centers (n=4) received the 'MOVEdiabetes' intervention, which consisted of personalized, individual face-to-face consultations by dietitians. Pedometers and monthly telephone WhatsApp messages were also used. Patients attending comparison health centers received usual care. The primary outcome was change in PA [Metabolic Equivalent(MET).min/week] after 12 months assessed by the Global Physical Activity Questionnaire. The secondary outcomes were changes in daily step counts, sitting time, weight, body mass index, glycated hemoglobin, blood pressure and lipids. Results: Of the 232 participants (59.1% female, mean (SD) age 44.2 (8.1) years), 75% completed the study. At 12 months, the mean change in MET.min/week was +631.3 (95% CI 369.4 to 893.2) in the intervention group (IG) vs +183.2 (95% CI 83.3 to 283.0) in the comparison group, with a significant between-group difference of +447.4 (95% CI 150.7 to 744.1). The odds of meeting PA recommendations were 1.9 times higher in the IG (95% CI 1.2 to 3.3). Significant between-group differences in favor of IG were detected for mean steps/day (+757, 95% CI 18 to 1531) and sitting time hours/ per day (-1.5, 95% CI -2.4 to -0.7). Clinical measures of systolic and diastolic blood pressure and triglycerides also showed significant intervention effects. Conclusions: 'MOVEdiabetes' was effective in increasing PA, the likelihood of meeting PA recommendations, and providing cardioprotective benefits in adults with T2D attending primary care.

AB - Objective: This study examined the impact of a multicomponent intervention to increase physical activity (PA) in adults with type 2 diabetes (T2D) in Oman. Research design and methods: This is a cluster randomized controlled trial in eight primary health centers. Participants were physically inactive, aged ≥18 years, and with no contraindication to PA. Patients attending intervention health centers (n=4) received the 'MOVEdiabetes' intervention, which consisted of personalized, individual face-to-face consultations by dietitians. Pedometers and monthly telephone WhatsApp messages were also used. Patients attending comparison health centers received usual care. The primary outcome was change in PA [Metabolic Equivalent(MET).min/week] after 12 months assessed by the Global Physical Activity Questionnaire. The secondary outcomes were changes in daily step counts, sitting time, weight, body mass index, glycated hemoglobin, blood pressure and lipids. Results: Of the 232 participants (59.1% female, mean (SD) age 44.2 (8.1) years), 75% completed the study. At 12 months, the mean change in MET.min/week was +631.3 (95% CI 369.4 to 893.2) in the intervention group (IG) vs +183.2 (95% CI 83.3 to 283.0) in the comparison group, with a significant between-group difference of +447.4 (95% CI 150.7 to 744.1). The odds of meeting PA recommendations were 1.9 times higher in the IG (95% CI 1.2 to 3.3). Significant between-group differences in favor of IG were detected for mean steps/day (+757, 95% CI 18 to 1531) and sitting time hours/ per day (-1.5, 95% CI -2.4 to -0.7). Clinical measures of systolic and diastolic blood pressure and triglycerides also showed significant intervention effects. Conclusions: 'MOVEdiabetes' was effective in increasing PA, the likelihood of meeting PA recommendations, and providing cardioprotective benefits in adults with T2D attending primary care.

KW - intervention

KW - physical activity

KW - primary health care

KW - type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85056220407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056220407&partnerID=8YFLogxK

U2 - 10.1136/bmjdrc-2018-000605

DO - 10.1136/bmjdrc-2018-000605

M3 - Article

VL - 6

JO - BMJ Open Diabetes Research and Care

JF - BMJ Open Diabetes Research and Care

SN - 2052-4897

IS - 1

M1 - e000605

ER -